{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:24:54Z","timestamp":1786987494590,"version":"build-2736575974"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014461","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000650","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.crad.2025.107167","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:51:48Z","timestamp":1762764708000},"page":"107167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Radiomics of hepatopancreatobiliary cancer diagnosis, management, and future prospects"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5161-3797","authenticated-orcid":false,"given":"D.","family":"Koku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1453-716X","authenticated-orcid":false,"given":"Y.","family":"Agarwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1457-4385","authenticated-orcid":false,"given":"M.","family":"Vithayathil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-6771","authenticated-orcid":false,"given":"E.O.","family":"Aboagye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12943-024-02140-6","article-title":"Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation","volume":"23","author":"Guo","year":"2024","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1470-2045(24)00599-0","article-title":"Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study","volume":"26","author":"Zhao","year":"2025","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.crad.2025.107167_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"3 Suppl 1","key":"10.1016\/j.crad.2025.107167_bib4","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.surg.2012.05.020","article-title":"Pancreatic ductal adenocarcinoma: long-term survival does not equal cure","volume":"152","author":"Ferrone","year":"2012","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.crad.2025.107167_bib5","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.crad.2025.107167_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejso.2020.03.222","article-title":"Epidemiology of HPB malignancy in the elderly","volume":"47","author":"Pericleous","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.crad.2025.107167_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: {GLOBOCAN} Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. {CA}","volume":"71","author":"Sung","year":"2021","journal-title":"A Cancer J Clin"},{"issue":"3","key":"10.1016\/j.crad.2025.107167_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018181494","article-title":"Liver imaging reporting and data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in At-Risk patients","volume":"289","author":"Chernyak","year":"2018","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.crad.2025.107167_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1102\/1470-7330.2012.0044","article-title":"Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring","volume":"12","author":"Hennedige","year":"2012","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.20728","article-title":"Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma","volume":"42","author":"Bolondi","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00330-019-06347-w","article-title":"Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules","volume":"30","author":"Mokrane","year":"2020","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.crad.2025.107167_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.acra.2020.04.027","article-title":"CT-Based radiomics nomogram: a potential tool for differentiating hepatocellular adenoma from hepatocellular carcinoma in the noncirrhotic liver","volume":"28","author":"Nie","year":"2021","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12880-019-0321-9","article-title":"Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.crad.2025.107167_bib16","series-title":"Pancreatic cancer mortality statistics","year":"2022"},{"issue":"2","key":"10.1016\/j.crad.2025.107167_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2023.04.003","article-title":"Artificial intelligence in pancreatic ductal adenocarcinoma imaging: a commentary on potential future applications","volume":"165","author":"Schuurmans","year":"2023","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.crad.2025.107167_bib18","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1007\/s00330-020-07307-5","article-title":"Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma","volume":"31","author":"Kang","year":"2021","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00330-020-07120-0","article-title":"The implications of missed or misinterpreted cases of pancreatic ductal adenocarcinoma on imaging: a multi-centered population-based study","volume":"31","author":"Kang","year":"2021","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.crad.2025.107167_bib20","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.pan.2020.07.410","article-title":"Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: stages of progression and potential benefits of early intervention: a retrospective study","volume":"20","author":"Singh","year":"2020","journal-title":"Pancreatology"},{"issue":"5","key":"10.1016\/j.crad.2025.107167_bib21","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2022.06.066","article-title":"Radiomics-based machine-learning models can detect pancreatic cancer on prediagnostic computed tomography scans at a substantial lead time before clinical diagnosis","volume":"163","author":"Mukherjee","year":"2022","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.crad.2025.107167_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.diii.2020.03.002","article-title":"Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features","volume":"101","author":"Park","year":"2020","journal-title":"Diagn Interv Imaging"},{"issue":"11","key":"10.1016\/j.crad.2025.107167_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113089","article-title":"CT-Based radiomics analysis to predict malignancy in patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the pancreas","volume":"12","author":"Tobaly","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"24","key":"10.1016\/j.crad.2025.107167_bib24","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.3748\/wjg.v26.i24.3458","article-title":"Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy","volume":"26","author":"Polk","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.crad.2025.107167_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107064","article-title":"Epidemiology of cholangiocarcinoma","volume":"51","author":"Qurashi","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.crad.2025.107167_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.crad.2025.107167_bib27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00261-021-03399-9","article-title":"Imaging mimickers of cholangiocarcinoma: a pictorial review","volume":"47","author":"Chiow","year":"2022","journal-title":"Abdom Radiol"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib28","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1038\/s41598-025-92263-7","article-title":"Comparison of MRI and CT based deep learning radiomics analyses and their combination for diagnosing intrahepatic cholangiocarcinoma","volume":"15","author":"Cheng","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib29","doi-asserted-by":"crossref","first-page":"7924","DOI":"10.1038\/s41598-022-11997-w","article-title":"Automated machine learning for differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma on multiphasic MRI","volume":"12","author":"Hu","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.crad.2025.107167_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"15","key":"10.1016\/j.crad.2025.107167_bib31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.crad.2025.107167_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crad.2025.107167_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ebiom.2019.10.057","article-title":"Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: a multi-institutional study","volume":"50","author":"Ji","year":"2019","journal-title":"EBioMedicine"},{"issue":"21","key":"10.1016\/j.crad.2025.107167_bib34","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.crad.2025.107167_bib35","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41416-019-0706-0","article-title":"MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma","volume":"122","author":"Wang","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.crad.2025.107167_bib36","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000603","article-title":"Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation","author":"Schindler","year":"2025","journal-title":"Liver Transplant"},{"issue":"11","key":"10.1016\/j.crad.2025.107167_bib37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.crad.2025.107167_bib38","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1007\/s00330-023-09591-3","article-title":"Incremental value of radiomics-based heterogeneity to the existing risk criteria in predicting recurrence of hepatocellular carcinoma after liver transplantation","volume":"33","author":"Nie","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.107167_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejrad.2019.05.010","article-title":"Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation","volume":"117","author":"Guo","year":"2019","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3350\/cmh.2017.0006","article-title":"Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma","volume":"23","author":"Kang","year":"2017","journal-title":"Clin Mol Hepatol"},{"issue":"96","key":"10.1016\/j.crad.2025.107167_bib41","first-page":"1689","article-title":"Analysis of patients with rapid aggressive tumor progression of hepatocellular carcinoma after percutaneous radiofrequency ablation","volume":"56","author":"Shiozawa","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.crad.2025.107167_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109955","article-title":"Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation","volume":"144","author":"Lv","year":"2021","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.crad.2025.107167_bib43","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2147\/JHC.S482760","article-title":"Multicenter integration of MR radiomics, deep learning, and clinical indicators for predicting hepatocellular carcinoma recurrence after thermal ablation","volume":"11","author":"Wang","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"issue":"6","key":"10.1016\/j.crad.2025.107167_bib44","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1159\/000480256","article-title":"Hepatic function during repeated TACE procedures and prognosis after introducing sorafenib in patients with unresectable hepatocellular carcinoma: multicenter analysis","volume":"35","author":"Hiraoka","year":"2017","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000512028","article-title":"Clinical-Radiomic analysis for pretreatment prediction of objective response to first transarterial chemoembolization in hepatocellular carcinoma","volume":"10","author":"Chen","year":"2021","journal-title":"Liver Cancer"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11547-023-01736-0","article-title":"A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram","volume":"129","author":"Liu","year":"2024","journal-title":"Radiol Med"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib47","article-title":"Radiomic features at contrast-enhanced CT predict proliferative hepatocellular carcinoma and its prognosis after transarterial chemoembolization","volume":"15","author":"He","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s12885-025-14079-y","article-title":"Multiparametric MRI-based radiomics and clinical nomogram predicts the recurrence of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization","volume":"25","author":"Guo","year":"2025","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.crad.2025.107167_bib49","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1007\/s00261-021-02992-2","article-title":"MRI-based radiomics: nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm","volume":"46","author":"Kuang","year":"2021","journal-title":"Abdom Radiol (New York)"},{"issue":"5","key":"10.1016\/j.crad.2025.107167_bib50","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s00261-024-04606-z","article-title":"Prediction of hepatocellular carcinoma response to radiation segmentectomy using an MRI-based machine learning approach","volume":"50","author":"Stocker","year":"2025","journal-title":"Abdom Radiol (New York)"},{"issue":"2","key":"10.1016\/j.crad.2025.107167_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11307-025-01992-8","article-title":"Potential of radiomics, dosiomics, and dose volume histograms for tumor response prediction in hepatocellular carcinoma following 90Y-SIRT","volume":"27","author":"Mansouri","year":"2025","journal-title":"Mol Imaging Biol"},{"issue":"20","key":"10.1016\/j.crad.2025.107167_bib52","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.crad.2025.107167_bib53","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"issue":"10481","key":"10.1016\/j.crad.2025.107167_bib54","article-title":"Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): a randomised, open-label, phase 3 trial","volume":"405","author":"Yau","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jamaoncol.2020.3381","article-title":"The current landscape of immune checkpoint blockade in hepatocellular carcinoma: a review","volume":"7","author":"Pinter","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.crad.2025.107167_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.04.017","article-title":"Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinoma","author":"Vithayathil","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.crad.2025.107167_bib57","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","article-title":"Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma","volume":"70","author":"Xu","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.crad.2025.107167_bib58","article-title":"Development and validation of a contrast-enhanced CT-Based radiomics nomogram for prediction of therapeutic efficacy of Anti-PD-1 antibodies in advanced HCC patients","volume":"11","author":"Yuan","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib59","article-title":"CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinoma","volume":"14","author":"Qi","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1148\/radiol.220329","article-title":"Artificial intelligence to predict lymph node metastasis at CT in pancreatic ductal adenocarcinoma","volume":"306","author":"Bian","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2025.107167_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101215","article-title":"Preoperative recurrence prediction in pancreatic ductal adenocarcinoma after radical resection using radiomics of diagnostic computed tomography","volume":"43","author":"Li","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.crad.2025.107167_bib62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejrad.2017.02.033","article-title":"Resectable pancreatic adenocarcinoma: role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes","volume":"90","author":"Cassinotto","year":"2017","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40644-024-00653-3","article-title":"Preoperative prediction of early recurrence in resectable pancreatic cancer integrating clinical, radiologic, and CT radiomics features","volume":"24","author":"Lee","year":"2024","journal-title":"Cancer Imaging"},{"issue":"6","key":"10.1016\/j.crad.2025.107167_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178961","article-title":"Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: an exploratory study","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.crad.2025.107167_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41698-019-0096-z","article-title":"A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer","volume":"3","author":"Nasief","year":"2019","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib66","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1186\/s12885-023-11432-x","article-title":"A deep-learning approach for segmentation of liver tumors in magnetic resonance imaging using UNet++","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.crad.2025.107167_bib67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00262-024-03644-2","article-title":"The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy","volume":"73","author":"Lu","year":"2024","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97796-1","article-title":"Radiomics-based model for predicting early recurrence of intrahepatic mass-forming cholangiocarcinoma after curative tumor resection","volume":"11","author":"Zhu","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.crad.2025.107167_bib69","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1007\/s00259-022-05765-1","article-title":"PET\/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival","volume":"49","author":"Fiz","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2025.107167_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.11.036","article-title":"Radiomics model of magnetic resonance imaging for predicting pathological grading and lymph node metastases of extrahepatic cholangiocarcinoma","volume":"470","author":"Yang","year":"2020","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.crad.2025.107167_bib71","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231319","article-title":"The image biomarker standardization initiative: standardized convolutional filters for reproducible radiomics and enhanced clinical insights","volume":"310","author":"Whybra","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2025.107167_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.07.005","article-title":"Reply to: \u201cReevaluating Feature Selection in Machine Learning-Based Radiomics for Hepatocellular Carcinoma: bridging the Gap Between Predictive Accuracy and Biological Relevance.\u201d","author":"Vithayathil","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.crad.2025.107167_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.05.025","article-title":"Reevaluating feature selection in machine learning-based radiomics for hepatocellular carcinoma: bridging the gap between predictive accuracy and biological relevance","author":"Takefuji","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.crad.2025.107167_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102260","article-title":"Habitat radiomics based on CT images to predict survival and immune status in hepatocellular carcinoma, a multi-cohort validation study","volume":"52","author":"Chen","year":"2025","journal-title":"Transl Oncol"},{"issue":"3","key":"10.1016\/j.crad.2025.107167_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011126","article-title":"Transfer learning radiomic model predicts intratumoral tertiary lymphoid structures in hepatocellular carcinoma: a multicenter study","volume":"13","author":"Long","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib76","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1109\/TMI.2020.3021254","article-title":"A novel multiresolution-statistical texture analysis architecture: radiomics-aided diagnosis of PDAC based on plain CT images","volume":"40","author":"Qiu","year":"2021","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.crad.2025.107167_bib77","first-page":"945","article-title":"End-to-end training of deep probabilistic CCA on paired biomedical observations","volume":"115","author":"Gundersen","year":"2020"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41698-024-00502-3","article-title":"Deep representation learning of tissue metabolome and computed tomography annotates NSCLC classification and prognosis","volume":"8","author":"Boubnovski Martell","year":"2024","journal-title":"Npj Precis Oncol"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib79","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/s12885-025-13978-4","article-title":"Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.crad.2025.107167_bib80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12876-023-02902-4","article-title":"A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy","volume":"23","author":"Li","year":"2023","journal-title":"BMC Gastroenterol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025003721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025003721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:29:30Z","timestamp":1774427370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926025003721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":80,"alternative-id":["S0009926025003721"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2025.107167","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiomics of hepatopancreatobiliary cancer diagnosis, management, and future prospects","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2025.107167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"107167"}}